Cisco (CSCO) dips on seventh straight quarterly sales decline >>> READ MORE

Top 10 Dow Dividend Stocks

10 of the most solid blue chips writing quarterly checks today

      View All  

#4: Pfizer

Pfizer (NYSE:PFE)Current Dividend Yield: 3.9%
Performance So Far in 2012: +5%

Pfizer (NYSE:PFE) outperformed the market nicely in 2011 with one of the best returns in the entire Dow Jones — 23% in gains, to be precise. While performance has cooled a bit and Pfizer was sitting on a loss earlier this year, the stock has come roaring back since February as defensive investments like healthcare return to favor.

Yes, long-term challenges at Pfizer are the same as the risks that persists across all of Big Pharma — looming patent expirations, challenges from generic medications and the frantic race to lock up patients in emerging markets. But the goose still is laying golden eggs for shareholders in the form of 22-cent quarterly dividends, with dividend payments dating back to 1901.

Looking forward, the company has a decent research pipeline with some up-and-coming drugs that could rotate in to prop up revenues. Most importantly for dividend investors, the company has $29 billion in cash on the books. Even if revenue hits a hiccup across 2012 — as it did in fiscal 2011 when it slid from $67.8 billion to $67.4 billion — the cash is there to preserve this juicy dividend. (For more, read why Louis Navellier thinks Pfizer stock is a strong buy now.)

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC